A Continuous process is a process where raw materials are continuously fed into a system at the same time as finished product is continuously removed at the end of the process train. The raw materials are processed in very small quantities, compared to batch processes, and in a controlled manner, which allows the operator to have consistent control over the critical process parameters and therefore the critical product quality attributes.
At GEA, we believe that continuous processing improves the quality of pharmaceutical end products: by focusing on quality during the whole product lifecycle, not just “tested in” quality; and by understanding the capability of your processes, managing sources of variability and decreasing any associated risks.
Our solution for continuous drying and particle processing plants is ConsiGma®, a 6 sigma-inspired manufacturing platform, incorporating different technologies to produce oral solid dosage forms in a continuous, cost-efficient way:
Zeigt 4 von 7 an
An indispensable part of the ConsiGma 4.0 portfolio, the Conductor 4.0 control system architecture ensures smooth operation and communication between the different elements of a pharmaceutical continuous manufacturing line
A highly integrated solution for continuous linear blending and direct compression, the ConsiGma® DC-LB lines offer all the advantages of continuous manufacturing: supply chain agility, small footprint, controlled blending and compression and improved quality.
A cost-effective solution for continuous dry blending and tablet compression using ribbon blending, ConsiGma® DC-RB lines make the advantages of continuous manufacturing (supply chain agility, small footprint and improved quality) available for all.
Highly integrated solutions for continuous wet granulation, drying and tablet compression, the ConsiGma® GC lines offer all the advantages of continuous manufacturing: supply chain agility, small footprint, controlled granulation and improved quality.
Nur eine Zeiterscheinung oder die Zukunft? In jedem Fall wird die hundertprozentige Nachverfolgbarkeit von Vials für pharmazeutische Unternehmen, die Gefriertrocknung einsetzen, ein zunehmend wichtiges Thema. Wir bei GEA verfolgen diese Entwicklung aufmerksam und prüfen mögliche Lösungen. Vor allem aber verfügen wir über die Erfahrung, den Sachverstand und das Know-how, sie umzusetzen.
Es gab Zeiten, in denen die Worte „alkoholfreies Bier“ und „schmeckt gut“ kaum je im selben Atemzug genannt wurden – schon gar nicht von den Konsumenten. Doch alkoholarme und alkoholfreie Biere haben eine enorme Entwicklung hingelegt und sind heute vielfach als Erfrischungsgetränke etabliert. Nicht zuletzt dank der Technologie von GEA.
At GEA, our commitment to engineering for a better world fuels our pursuit of innovative solutions that enhance patient care and safety. One of our most promising ventures in recent years is aseptic spray drying – a technology that promises to revolutionize pharmaceutical manufacturing.